Loading clinical trials...
Loading clinical trials...
Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients: A Phase 2A, Randomized, Placebo-Controlled Trial
Conditions
Interventions
Phentermine-Topiramate
Placebo
Locations
1
United States
University of California San Diego
La Jolla, California, United States
Start Date
December 18, 2020
Primary Completion Date
June 30, 2024
Completion Date
June 30, 2024
Last Updated
May 16, 2023
NCT07543666
NCT07351045
NCT07037459
NCT07244458
NCT07508241
NCT05746039
Lead Sponsor
University of California, San Diego
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions